David Pépin

David Pépin is a Co-Founder & Advisor at Oviva Therapeutics. David has also served as an Assistant Professor at Harvard Medical School and Massachusetts General Hospital from May 2016 to November 2021. Prior to that, they were a co-founder at Provulis LLC from July 2015 to May 2020 where they were involved in various aspects of the company, including drafting term sheets, negotiating licensing agreements, presenting to investors, securing financing, drafting patents, and managing intellectual property. David has also served as an Instructor and Assistant in Surgery at Harvard Medical School from January 2014 to May 2016.

David Pépin has a Ph.D in Cellular and Molecular Medicine from the University of Ottawa / Université d'Ottawa, and a Bachelor of Science (B.Sc.) in Biopharmaceutical sciences, specialty in genomics, also from the University of Ottawa / Université d'Ottawa. David is a Post-Doctoral Fellow in Pediatric Surgical Research Laboratories at Harvard Medical School, and has a certification from Applied Biosystems in SOLiD System Training Course - (next gen sequencing).